Results of the Collis-Nissen gastroplasty to control reflux disease in patients who have Barrett's esophagus

Chest Surgery Clinics of North America

Volumn 12, Issue 1, 2002, Pages 127-147

  Chen, Long Qi ^a   Ferraro, Pasquale ^a   Duranceau, Andre ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CLINICAL FEATURE; ESOPHAGOGRAPHY; ESOPHAGUS MOTILITY; ESOPHAGUS PH; ESOPHAGUS SCINTISCANNING; GASTROESOPHAGEAL REFLUX; GASTROPLASTY; HUMAN; MORTALITY; PRIORITY JOURNAL; RELIABILITY; REVIEW; STOMACH FUNDOPLICATION; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036187817     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3359(03)00070-X     Document Type: Review

References (88)

1. Radiologic diagnosis of Barrett's esophagus: Critical analysis of 65 cases
2. Alkaline gastroesophageal reflux: Implications in the development of complications in Barrett's columnar-lined lower esophagus
3. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats
4. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium
5. The histopathology of treated Barrett's esophagus: Squamous reepithelialization after acid suppression and laser and photodynamic therapy
6. Surgical therapy in patients with failed antireflux repairs
7. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery
8. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation
9. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus
10. Proliferative activity in Barrett's esophagus before and after antireflux surgery
11. Results of the Collis-Nissen gastroplasty in patients with Barrett's esophagus
12. Efficacy of radiologic studies in the detection of Barrett's esophagus
13. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus
14. An operation for hiatus hernia with short esophagus
15. Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus
16. Gastroesophageal reflux in achalasia. When is reflux really reflux?
17. Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation
18. Late results of a randomized clinical trial comparing total fundoplication versus calibration of the cardia with posterior gastropexy
19. Stapled, uncut gastroplasty for hiatal hernia: 12-Year follow-up
20. Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus
21. Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus
22. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen
23. Short esophagus: Analysis of predictors and clinical implications
24. The Collis-Nissen operation in the treatment of reflux due to esophageal stenoses associated with brachioesophagus
25. Depth of Barrett's esophaus in 52 surgical specimens - Possible clinical implications
26. The columnar-lined esophagus
27. Pathophysiology and natural history of acquired short esophagus
28. Barrett's esophagus, dysplasia, and adenocarcinoma
29. Development of adenocarcinoma in Barrett's oesophagus after successful antireflux surgery
30. Barrett's esophagus: Development of dysplasia and adenocarcinoma
31. Reflux control following gastroplasty
32. Secretory function of Barrett's epithelium
33. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus
34. Failed antireflux surgery: What have we learned from reoperations?
35. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy
36. Molecular evolution of the metaplasiadysplasia-adenocarcinoma sequence in the esophagus
37. Postoperative function following laparoscopic Collis gastroplasty for shortened esophagus
38. Laparoscopic Collis gastroplasty and Nissen fundoplication. A new technique for the management of esophageal foreshortening
39. Changes in overnight fasting intragastric pH show poor correlation with duodenogastric bile reflux in normal subjects
40. Barrett esophagus: Decreased esophageal clearance shown by radionuclide esophageal scintigraphy
41. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus
42. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus
43. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus
44. Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin
45. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized
46. Histological and anatomic changes in Barrett's esophagus after antireflux surgery
47. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease
48. Collis-Nissen gastroplasty fundoplication for complicated gastro-oesophageal reflux disease
49. Apoptosis and cancer: The failure of controls on cell death and cell survival
50. Adenocarcinoma of the neo-esophagus after Collis gastroplasty
51. Role of antireflex surgery against dysplasia in Barrett's esophagus
52. Barretts's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance?
53. The preoperative predictability of the short esophagus in patients with stricture or paraesophageal hernia
54. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium
55. Combined Collis-Nissen reconstruction of the esophagogastric junction
56. Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study
57. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
58. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus
59. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients
60. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma
61. The surgical management of Barrett's esophagus
62. Barrett's esophagus and esophageal adenocarcinoma
63. A modified gastroplasty
64. Collis-Nissen gastroplasty for shortened esophagus: Long-term evaluation
65. Reoperation after failed antireflux surgery
66. Regression and progression of Barrett's oesophagus after antireflux surgery
67. Clinical trial of omeprazole in patients with Barrett's oesophagus
68. Squamous islands in Barrett's esophagus: What lies underneath?
69. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus
70. Barrett's oesophagus and proton pump inhibitors: A pathological perspective
71. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett
72. Failure of antireflux surgery: Causes and management strategies
73. Functional foregut abnormalities in Barrett's esophagus
74. Bile reflux in benign and malignant Barrett's esophagus: Effect of medical acid suppression and Nissen fundoplication
75. Assessment of non-acid esophageal reflux: Comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring
76. Surgical treatment after the failed antireflux operation
77. Adenocarcinoma arising in Barrett's esophagus after total gastrectomy
78. Radionuclide esophagogram
79. Collis's operation for brachyesophagus (49 patients)
80. Uncut Collis-Nissen fundoplication: Learning curve and long-term results
81. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value?
82. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus
83. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: Immediate and mid term results
84. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus
85. The diagnosis of Barrett's esophagus: Goblets, goblets, goblets
86. Reflux-induced apoptosis of the esophageal mucosa is inhibited in Barrett's epithelium
87. Regression of columnar-lined (Barrett's) oesophagus with omeprazole 40 mg daily: Results of 5 years of continuous therapy
88. Effect of antireflux operation on Barrett's mucosa